⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31078599 | 1.00 | — | — | |
| SCHEMBL12799982 | 0.93 | TSHR (0.37) | — | |
| SCHEMBL7037354 | 0.85 | LMNA (0.35) | — | |
| SCHEMBL9422737 | 0.85 | — | — | |
| SCHEMBL18477542 | 0.81 | CYP3A4 (0.33) | — | |
| SCHEMBL31170214 | 0.80 | TSHR (0.42) | — | |
| SCHEMBL15282616 | 0.80 | SLC1A2 (0.33) | — | |
| SCHEMBL17878109 | 0.79 | — | — | |
| SCHEMBL16647371 | 0.79 | — | — | |
| SCHEMBL1837522 | 0.79 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 33 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4720035-A1 | LIPID COMPOUNDS, COMPOSITIONS, AND USES THEREOF | LIBERATE BIO, INC. (US) | 2026-04-08 | — | — | EP | disclosed |
| WO-2025087365-A1 | METTL3 INHIBITOR | 杭州邦顺制药有限公司 | 2025-05-01 | — | — | WO | disclosed |
| CN-119899188-A | METTL3 inhibitors | 杭州邦顺制药有限公司 | 2025-04-29 | — | — | CN | disclosed |
| WO-2024249525-A1 | LIPID COMPOUNDS, COMPOSITIONS, AND USES THEREOF | LIBERATE BIO, INC. (US) | 2024-12-05 | — | — | WO | disclosed |
| CN-118451079-A | Benzopiperidine derivative modulators, methods of preparation and uses thereof | 上海翰森生物医药科技有限公司 | 2024-08-06 | — | — | CN | disclosed |
| US-20230364070-A1 | PYRROLO[3,2-C]PYRIDIN-4-ONE DERIVATIVES USEFUL IN THE TREATMENT OF CANCER | ANTARES THERAPEUTICS, INC. | 2023-11-16 | — | — | US | disclosed |
| WO-2023125935-A1 | BENZOPYRIDINE DERIVATIVE REGULATOR, AND PREPARATION METHOD THEREFOR AND USE THEREOF | 上海翰森生物医药科技有限公司 | 2023-07-06 | — | — | WO | disclosed |
| WO-2023125935-A1 | BENZOPYRIDINE DERIVATIVE REGULATOR, AND PREPARATION METHOD THEREFOR AND USE THEREOF | 上海翰森生物医药科技有限公司 | 2023-07-06 | — | — | WO | disclosed |
| US-20230135215-A1 | COMPOUNDS AS CDK2/4/6 INHIBITORS | FOCHON BIOSCIENCES, LTD. (CN) | 2023-05-04 | — | — | US | disclosed |
| EP-4110782-A1 | COMPOUNDS AS CDK2/4/6 INHIBITORS | Fochon Biosciences, Ltd. (CN) | 2023-01-04 | — | — | EP | disclosed |
| US-20160185778-A1 | DERIVATIVES AND METHODS OF TREATING HEPATITIS B INFECTIONS | NOVIRA THERAPEUTICS, INC. | 2016-06-30 | — | — | US | disclosed |
| US-20160185778-A1 | DERIVATIVES AND METHODS OF TREATING HEPATITIS B INFECTIONS | NOVIRA THERAPEUTICS, INC. | 2016-06-30 | — | — | US | disclosed |
| JP-2009215255-A | BICYCLO[3.1.0]HEXANE-1-CARBOXYLIC ACID DERIVATIVE, ITS ADDITION SALT AND PDE INHIBITOR HAVING THEM AS EFFECTIVE COMPONENTS | KYORIN PHARMACEUT CO LTD | 2009-09-24 | — | — | JP | disclosed |
| EP-2001880-A2 | HETEROBICYCLIC PYRAZOLE COMPOUNDS AND METHODS OF USE | Array Biopharma, Inc. (US) | 2008-12-17 | — | — | EP | disclosed |
| WO-2007103308-A2 | HETEROBICYCLIC PYRAZOLE COMPOUNDS AND METHODS OF USE | ARRAY BIOPHARMA INC. (US) | 2007-09-13 | — | — | WO | disclosed |
| EP-0350187-B1 | Antiparasitic agents | PFIZER LTD (GB) | 1994-01-05 | — | — | EP | disclosed |
| US-5112746-A | METHOD FOR MAKING ANTIPARASITIC AGENTS | PFIZER INC. (US) | 1992-05-12 | — | — | US | disclosed |
| US-5057498-A | ANTIPARASTIC AGENTS | PFIZER INC. (US) | 1991-10-15 | — | — | US | disclosed |
| US-4980370-A | Antiparasitic agents | PFIZER INC. (US) | 1990-12-25 | — | — | US | disclosed |
| EP-0350187-A2 | Antiparasitic agents | Pfizer Limited (GB) | 1990-01-10 | — | — | EP | disclosed |